Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Long-term Extension Study to Evaluate the Safety and Efficacy of CRN00808 in Subjects With Acromegaly (ACROBAT Advance)

NCT04261712 is registered in ClinicalTrials.gov with Crinetics Pharmaceuticals Inc. as lead sponsor.

NCT NCT04261712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04261712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Long-term Extension Study to Evaluate the Safety and Efficacy of CRN00808 in Subjects With Acromegaly (ACROBAT Advance)
Lead sponsor
Crinetics Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Terminated
Start date
January 29, 2020
Completion date
June 30, 2026
Enrollment
43 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly